Managing IP’s most-read stories in February 2019

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP’s most-read stories in February 2019

Artificial intelligence, cannabis and EU copyright were just some of the highlights in our news coverage in February – below we detail the five most-read stories for the month

1.       AI and patents poll part one: knowledge needed


At number one is the first part of a survey on artificial intelligence and patents. The survey was carried out by Patent Strategy, a new offering from Managing IP. You can read the results here.

2.       First infringement case could be ‘seminal moment’ for us cannabis sector

The second most-read story is on the hot topic of cannabis. Here we reported that some biotech companies believe that the future enforceability of cannabis patents rests on one particular case.

3.       EU copyright directive agreed in “present for creatives”

Next up is the political agreement to introduce the new EU Copyright Directive, which has divided opinion among interest groups; some see it as a win for copyright owners. You can read more here

4.       Big data may drive IP enforcement, businesses reveal

Number four is on big data. As you can read here in-house sources explain that big data tools could be increasingly used for analyses surrounding IP litigation as the technology becomes more reliable.

5.       Generics discuss fallout from major pharma patent cases

The fifth most-read story looks at the latest US pharmaceutical patent case law. Generic companies tell us which decisions they are most concerned about and why. You can see their views here.

more from across site and SHARED ros bottom lb

More from across our site

The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Gift this article